Literature DB >> 23994200

Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.

Paola Brun1, Maria Cecilia Giron, Marsela Qesari, Andrea Porzionato, Valentina Caputi, Chiara Zoppellaro, Serena Banzato, Alessia Rosaria Grillo, Lisa Spagnol, Raffaele De Caro, Daniela Pizzuti, Vito Barbieri, Antonio Rosato, Giacomo Carlo Sturniolo, Diego Martines, Giovanni Zaninotto, Giorgio Palù, Ignazio Castagliuolo.   

Abstract

BACKGROUND & AIMS: In the intestines, Toll-like receptor 2 (TLR2) mediates immune responses to pathogens and regulates epithelial barrier function; polymorphisms in TLR2 have been associated with inflammatory bowel disease phenotype. We assessed the effects of TLR2 signaling on the enteric nervous system (ENS) in mice.
METHODS: TLR2 distribution and function in the ileal neuromuscular layer of mice were determined by immunofluorescence, cytofluorimetric analysis, immunoprecipitation, and immunoblot analyses. We assessed morphology and function of the ENS in Tlr2(-/-) mice and in mice with wild-type Tlr2 (wild-type mice) depleted of intestinal microbiota, using immunofluorescence, immunoblot, and gastrointestinal motility assays. Levels and signaling of glial cell line-derived neurotrophic factor (GDNF) were determined using quantitative reverse transcriptase polymerase chain reaction, immunohistochemistry, and immunoprecipitation analyses. Colitis was induced by administration of dextran sulfate sodium or 2,4 dinitrobenzensulfonic acid to Tlr2(-/-) mice after termination of GDNF administration.
RESULTS: TLR2 was expressed in enteric neurons, glia, and smooth muscle cells of the intestinal wall. Tlr2(-/-) mice had alterations in ENS architecture and neurochemical profile, intestinal dysmotility, abnormal mucosal secretion, reduced levels of GDNF in smooth muscle cells, and impaired signaling via Ret-GFRα1. ENS structural and functional anomalies were completely corrected by administration of GDNF to Tlr2(-/-) mice. Wild-type mice depleted of intestinal microbiota had ENS defects and GDNF deficiency, similar to Tlr2(-/-) mice; these defects were partially restored by administration of a TLR2 agonist. Tlr2(-/-) mice developed more severe colitis than wild-type mice after administration of dextran sulfate sodium or 2,4 dinitrobenzensulfonic acid; colitis was not more severe if Tlr2(-/-) mice were given GDNF before dextran sulfate sodium or 2,4 dinitrobenzensulfonic acid.
CONCLUSIONS: In mice, TLR2 signaling regulates intestinal inflammation by controlling ENS structure and neurochemical coding, along with intestinal neuromuscular function. These findings provide information as to how defective TLR2 signaling in the ENS affects inflammatory bowel disease phenotype in humans.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2,4 dinitrobenzensulfonic acid; DNBS; EGC; ENS; GDNF; GFAP; IBD; Immune Regulation; Innate Immunity; LMMP; Microbe; TLR2; Toll-like receptor 2; Ulcerative Colitis; WT; enteric glial cells; enteric nervous system; glial cell line-derived neurotrophic factor; glial fibrillary acidic protein; inflammatory bowel diseases; longitudinal smooth muscle-myenteric plexus; mRNA; messenger RNA; nNOS; neuronal nitric oxide synthase; rGDNF; recombinant histidine-tagged GDNF; wild type

Mesh:

Substances:

Year:  2013        PMID: 23994200     DOI: 10.1053/j.gastro.2013.08.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  110 in total

Review 1.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

2.  The gut microbiota keeps enteric glial cells on the move; prospective roles of the gut epithelium and immune system.

Authors:  Panagiotis S Kabouridis; Reena Lasrado; Sarah McCallum; Song Hui Chng; Hugo J Snippert; Hans Clevers; Sven Pettersson; Vassilis Pachnis
Journal:  Gut Microbes       Date:  2015

Review 3.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 4.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

Review 5.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

Review 6.  Neuroimmune regulation during intestinal development and homeostasis.

Authors:  Henrique Veiga-Fernandes; Vassilis Pachnis
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 7.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 8.  An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Authors:  Marta Wlodarska; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 9.  Bacterial Signaling to the Nervous System through Toxins and Metabolites.

Authors:  Nicole J Yang; Isaac M Chiu
Journal:  J Mol Biol       Date:  2017-01-06       Impact factor: 5.469

Review 10.  Enteric glial cells and their role in the intestinal epithelial barrier.

Authors:  Yan-Bo Yu; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.